Cleveland Clinic Abu Dhabi: A New Era of Cardiac Excellence

By Danélia Botes

November 5, 2023

A Landmark Achievement in Healthcare

The Department of Health – Abu Dhabi (DoH) has declared Cleveland Clinic Abu Dhabi, a component of the M42 network, as a Centre of Excellence (CoE) for Adult Cardiac Surgery (ACS). This significant announcement is a testament to Abu Dhabi’s commitment to delivering world-class healthcare services to its community and reinforces its standing as a leading healthcare destination.

Centre of Excellence for Adult Cardiac Surgery: A New Standard in Cardiac Care

As an ACS CoE, Cleveland Clinic Abu Dhabi offers a comprehensive range of cardiac surgery and structural heart disease interventions. These services are provided by a team of highly experienced cardiologists and some of the world’s most reputable surgeons. The Clinic boasts dedicated cardiac surgery ICU facilities and cardiac operating rooms, supported by core services that include multidisciplinary cardiovascular medicine, interventional cardiology, electrophysiology, and a pioneering structural heart programme.

H.E. Dr. Noura Al Ghaithi, Undersecretary of the DoH, emphasised the importance of the CoE programme in elevating healthcare outcomes and increasing competitiveness across the sector. She expressed delight at the announcement and looked forward to the continuous contributions from partners to enhance the healthcare sector’s excellence.

Hasan Jasem Al Nowais, Chairman of Cleveland Clinic Abu Dhabi and Managing Director and Group Chief Executive Officer of M42, highlighted the Clinic’s establishment as a regional and global benchmark for complex care. He reiterated their commitment to excellence and the vision of providing world-class complex care to patients in the UAE and across the region.

Reference url

Recent Posts

Alzheimer's Treatments
                 

Alzheimer’s Treatments: Evaluating Emerging Therapies and NICE’s Stance on Lecanemab

🌟 #SyenzaNews: The landscape of Alzheimer’s treatment is evolving with new drugs on the horizon. While NICE recently found lecanemab’s benefits too small to justify its cost, promising treatments like donanemab, remternetug, and blarcamesine show potential. Learn more about these emerging therapies and their impact on Alzheimer’s care. 💊🧠
#AlzheimersResearch #HealthcareInnovation #PharmaNews #DementiaCare

Preventing falls among older adults
          

Preventing Falls Among Older Adults: A Vital Healthcare Imperative

🧓👵 Falls among the elderly are a significant concern. Read our latest insight to explore the awareness and preventive measures of fall risks among older adults in Buraidah, Qassim. Discover key findings and strategies to reduce fall incidents.

#SyenzaNews #ElderlyCare #FallPrevention #HealthAwareness #PatientSafety

Let’s work together to raise awareness and implement effective strategies to prevent falls among older adults.

Hevolution Foundation ageing research
             

In Saudi Arabia, the Hevolution Foundation is Reshaping Ageing Research

The quest for healthier ageing is gaining momentum! 🌟 Discover how the Hevolution Foundation is transforming longevity research with a $1 billion annual commitment. Their groundbreaking work is set to reshape the future of healthspan for everyone. 🌍💡

#SyenzaNews #AgeingResearch #Healthspan #Longevity #HevolutionFoundation #HealthcareInnovation #FutureOfHealth

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

JOIN NEWSLETTER




SERVICES

© 2024 Syenza™. All rights reserved.